UNSPSC 41141614: Creatine kinase - mb

In this classification, this entry connotes a Creatine kinase - mb enzyme that is used in clinical chemistry testing.

UNSPSC 41141614 Creatine kinase - mb is a Commodity code that maps poorly to the recent state and local solicitation activity in the source. The code nominally identifies a single clinical chemistry analyte — creatine kinase MB isoenzyme — but the most recent opportunities tagged with this code actually solicit next-generation sequencing consumables, solid-phase extraction disks, culture media, chromatography columns, extraction equipment, and diagnostic reagent kits for pathogen detection, foodborne illness surveillance, and wastewater testing. Only one opportunity (Mississippi State Department of Health sole source for Clear Labs kits) touches genomic sequencing, which approaches the chemistry-diagnostic space, but the alignment is marginal. The issuing bodies across the nine recent opportunities span state health departments (Texas HHSC/DSHS, Mississippi State Department of Health), a municipal government (City of Philadelphia), a university research center (University of Texas Health Science Center at San Antonio), and the State of California, with Texas dominating the sample through five distinct IFB procurements. The work actually being purchased covers laboratory supplies, analytical standards, molecular and microbial diagnostic reagents, and specialized instrumentation — none of which are clinical chemistry serum or plasma tests for creatine kinase MB in the traditional sense.

Recent activity clusters in Texas (five IFBs from HHSC/DSHS between February and June 2026 for respiratory pathogen sequencing kits, culture media, drinking water testing reagents, gas chromatography consumables, and analytical standards) and Mississippi (two sole source procurements in April 2026 for whole genome sequencing reagents from Illumina and Clear Labs), with single opportunities in California (mycobacterial culture reagents and forensic spiking solutions, April 2026), Pennsylvania (Philadelphia extraction columns micro purchase, May 2026), and Texas higher education (UTHSA RFP for a comprehensive biotech and clinical diagnostics catalog, May 2026). Representative recent solicitations include the Texas HHSC IFB HHS0017272 for consumable respiratory pathogen detection kits with MiSeq sequencing capacity (due May 19, 2026), and the Mississippi State Department of Health sole source RFX 3150006813 for Illumina whole genome sequencing kits and reagents totaling $393,667.98 (objection deadline May 14, 2026). The code shows no alignment to single-analyte serum chemistry testing and should be re-evaluated or treated as dormant for creatine kinase MB procurement purposes.